Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129087) titled 'Exploring the induction of ferroptosis in lung cancer cells mediated by genistein through the TP53/SLC7A11/GPX4 axis based on network pharmacology and machine learning' on July 30.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: The First Affiliated Hospital of Dalian Medical University
Condition:
lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-30
Target Sample Size: Cancer tissue:5;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=335409
Published by HT Digital Content Service...